The estimated Net Worth of Robert J Michel is at least $210 Tausend dollars as of 27 March 2024. Mr. Michel owns over 750 units of Bio-Key International stock worth over $26,103 and over the last 16 years he sold BKYI stock worth over $184,057. In addition, he makes $0 as Independent Director at Bio-Key International.
Robert has made over 15 trades of the Bio-Key International stock since 2009, according to the Form 4 filled with the SEC. Most recently he bought 750 units of BKYI stock worth $6,525 on 27 March 2024.
The largest trade he's ever made was selling 21,502 units of Bio-Key International stock on 8 June 2012 worth over $184,057. On average, Robert trades about 730 units every 77 days since 2009. As of 27 March 2024 he still owns at least 11,300 units of Bio-Key International stock.
You can see the complete history of Mr. Michel stock trades at the bottom of the page.
Robert J. Michel CPA serves as Independent Director of the Company. He has served as a Director of the Company since April 10, 2017. He has over 30 years of accounting and financial management experience. Since September, 2018, he has served as the Chief Financial Officer of Daxor Corporation (NYSE MKT: DXR), a medical device manufacturing company specializing in blood volume analysis. Prior to Daxor, from November, 2017 until September 2018, Mr. Michel served as the CFO of Roadway Moving, Inc., a transportation, moving and storage company located in New York City. Immediately prior to Roadway Moving, Inc., Mr. Michel served as a consultant with Feuer & Orlando, LLP, a New York City based CPA firm, from May, 2016 until November 2017. From 2009 until March, 2016, Mr. Michel was the Chief Financial Officer of Asta Funding, Inc. (Nasdaq: ASFI), a diversified financial services company operating in five reportable segments in the United States, with the consumer receivables segment also operating in South America. Mr. Michel was responsible for all financial matters and SEC reporting. From 2004 until 2009, Mr. Michel served as the Controller and the Director of Financial Reporting and Compliance for Asta Funding. Mr. Michel is a certified public accountant, earned a MBA in Taxation from St. John’s University, and a BS in Business Administration from Villanova University. Mr. Michel gained his public accounting experience at Price Waterhouse in New York, the predecessor firm of pwc.
Robert Michel is 63, he's been the Independent Director of Bio-Key International since 2017. There are 3 older and 11 younger executives at Bio-Key International. The oldest executive at Bio-Key International Inc. is Thomas Bush, 68, who is the Independent Director.
Robert's mailing address filed with the SEC is C/O BIO-KEY INTERNATIONAL, INC., 101 CRAWFORDS CORNER RD, SUITE 4116, HOLMDEL, NJ, 07733.
Over the last 21 years, insiders at Bio-Key International have traded over $0 worth of Bio-Key International stock and bought 12,751,535 units worth $6,447,278 . The most active insiders traders include Fong Wong Kwok, James David Sullivan und Michael W Depasquale. On average, Bio-Key International executives and independent directors trade stock every 61 days with the average trade being worth of $654,578. The most recent stock trade was executed by Michael W Depasquale on 4 December 2023, trading 20,000 units of BKYI stock currently worth $3,600.
bio-key international, inc. (otcqb: bkyi), is a trusted provider of enterprise and consumer biometric software and hardware authentication solutions. established in 1993 customers include the fortune 500, government agencies, healthcare organizations, call centers, schools, retailers, and oem partners. in 2016, the company introduced a line of compact fingerprint readers that have been tested and qualified for use with windows hello. these affordable and easy to install / easy to use readers are available through amazon, microsoft, dell.com and other leading retailers. at the consumer electronic show 2017, bio-key launched a series of biometric padlocks. touchlock won top product and was featured on more than 30+ morning television shows. looking into the future bio-key remains committed to developing the biometric of things (bot) a series of biometrically enabled consumer friendly products. all inspired by the power of a touch.
Bio-Key International executives and other stock owners filed with the SEC include: